Shaolu Zhang

423 total citations
10 papers, 222 citations indexed

About

Shaolu Zhang is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Shaolu Zhang has authored 10 papers receiving a total of 222 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Oncology and 1 paper in Genetics. Recurrent topics in Shaolu Zhang's work include PARP inhibition in cancer therapy (4 papers), DNA Repair Mechanisms (3 papers) and Cancer therapeutics and mechanisms (1 paper). Shaolu Zhang is often cited by papers focused on PARP inhibition in cancer therapy (4 papers), DNA Repair Mechanisms (3 papers) and Cancer therapeutics and mechanisms (1 paper). Shaolu Zhang collaborates with scholars based in China, Israel and United States. Shaolu Zhang's co-authors include Dexin Kong, Yuxu Zhong, Zhe Zhang, Xin Peng, Baoquan Zhao, Hongyan Liu, Moshe Elkabets, Bo Du, Ran Wang and Wei Wang and has published in prestigious journals such as Chemical Engineering Journal, Molecular Cancer and Advanced Science.

In The Last Decade

Shaolu Zhang

8 papers receiving 219 citations

Peers

Shaolu Zhang
Comparison fields: 5 of 56
  • Molecular Biology 133
  • Oncology 72
  • Cancer Research 37
  • Pulmonary and Respiratory Medicine 32
  • Immunology 23
Karen Boland Ireland
Yunwei Han China
Jingyan Gao China
Jiejuan Lai China
Jia Chai China
Jun Pu China
Anja Bastian United States
Federico Lucantoni Spain
Flavien Devun France
Leonardo Carmo de Andrade-Lima Brazil
Karen Boland Ireland View profile →
Citations per field, relative to Shaolu Zhang
Shaolu Zhang · 1×
Citations per year, relative to Shaolu Zhang
Shaolu Zhang · 1×

Countries citing papers authored by Shaolu Zhang

Since Specialization
Citations

This map shows the geographic impact of Shaolu Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaolu Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaolu Zhang more than expected).

Fields of papers citing papers by Shaolu Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaolu Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaolu Zhang. The network helps show where Shaolu Zhang may publish in the future.

Co-authorship network of co-authors of Shaolu Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Shaolu Zhang. A scholar is included among the top collaborators of Shaolu Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaolu Zhang. Shaolu Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
# Title Journal Authors Indexed citations
1 Jab1 regulates HRR mRNA stability to modulate PARP inhibitor sensitivity in triple-negative breast cancer Molecular Cancer Xin Peng, Yingying Wang et al. 0
2 A novel pan-PI3K inhibitor KTC1101 synergizes with anti-PD-1 therapy by targeting tumor suppression and immune activation Molecular Cancer Xin Peng, Xin Huang et al. 22
3 Stellettin B Sensitizes Glioblastoma to DNA‐Damaging Treatments by Suppressing PI3K‐Mediated Homologous Recombination Repair Advanced Science Xin Peng, Shaolu Zhang et al. 19
4 Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagy Journal of Experimental & Clinical Cancer Research Xin Peng, Shaolu Zhang et al. 22
5 BKM120 sensitizes glioblastoma to the PARP inhibitor rucaparib by suppressing homologous recombination repair Cell Death and Disease Shaolu Zhang, Xin Peng et al. 35
6 Digoxin Enhances the Anticancer Effect on Non-Small Cell Lung Cancer While Reducing the Cardiotoxicity of Adriamycin Frontiers in Pharmacology Yingying Wang, Qian Ma et al. 49
7 Biomimetic carrier-free nanoparticle delivers digoxin and doxorubicin to exhibit synergetic antitumor activity in vitro and in vivo Chemical Engineering Journal Zhe Zhang, Yingying Wang et al. 24
8 Application of Remote Sensing Information Technology and Geographic Information System in Land Dynamic Monitoring Shaolu Zhang 0
9 Atorvastatin Exerts Antileukemia Activity via Inhibiting Mevalonate-YAP Axis in K562 and HL60 Cells Frontiers in Oncology Lei Zhang, Ting Chen et al. 18
10 DT-13 Inhibits Proliferation and Metastasis of Human Prostate Cancer Cells Through Blocking PI3K/Akt Pathway Frontiers in Pharmacology Zhengming Wang, Yingying Wang et al. 33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026